Mark A Babizhayev Selected Research

imidazole

4/2015	The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
1/2015	Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases.
1/2015	An "enigmatic" L-carnosine (β-alanyl-L-histidine)? Cell proliferative activity as a fundamental property of a natural dipeptide inherent to traditional antioxidant, anti-aging biological activities: balancing and a hormonally correct agent, novel patented oral therapy dosage formulation for mobility, skeletal muscle power and functional performance, hypothalamic-pituitary- brain relationship in health, aging and stress studies.
5/2014	L-carnosine modulates respiratory burst and reactive oxygen species production in neutrophil biochemistry and function: may oral dosage form of non-hydrolized dipeptide L-carnosine complement anti-infective anti-influenza flu treatment, prevention and self-care as an alternative to the conventional vaccination?
3/2014	The detox strategy in smoking comprising nutraceutical formulas of non-hydrolyzed carnosine or carcinine used to protect human health.
1/2014	Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities.
12/2013	Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants.
8/2012	Structural and functional properties, chaperone activity and posttranslational modifications of alpha-crystallin and its related subunits in the crystalline lens: N-acetylcarnosine, carnosine and carcinine act as alpha- crystallin/small heat shock protein enhancers in prevention and dissolution of cataract in ocular drug delivery formulations of novel therapeutic agents.
7/2011	Designation of imidazole-containing dipeptides as pharmacological chaperones.
1/2011	Water-structuring technology with the molecular chaperone proteins: indicated application of the α-crystallin domains and imidazole-containing peptidomimetics in cosmetic skin care systems or dermatological therapeutic drug carrier formulations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Babizhayev Research Topics

Disease

29	Cataract (Cataracts) 12/2016 - 01/2002
16	Eye Diseases (Eye Disease) 12/2016 - 01/2009
9	Macular Degeneration (Age-Related Maculopathy) 08/2012 - 01/2009
7	Vision Disorders (Hemeralopia) 01/2016 - 01/2009
7	Diabetes Mellitus 04/2015 - 01/2005
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2016 - 01/2009
6	Inflammation (Inflammations) 03/2014 - 11/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 11/2010
5	Skin Diseases (Skin Disease) 10/2012 - 01/2010
4	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2012 - 01/2009
4	Glaucoma 07/2011 - 01/2005
3	Wounds and Injuries (Trauma) 12/2015 - 01/2012
3	Infections 05/2014 - 01/2012
3	Human Influenza (Influenza) 05/2014 - 01/2012
2	Diabetes Complications 04/2015 - 10/2012
2	Hyperglycemia 04/2015 - 01/2009
2	Neoplasms (Cancer) 01/2015 - 01/2014
2	Metabolic Diseases (Metabolic Disease) 01/2015 - 01/2015
2	Endophthalmitis (Ophthalmia) 04/2013 - 01/2004
2	Retinal Detachment (Retinal Detachments) 04/2013 - 01/2004
2	Pneumonia (Pneumonitis) 01/2013 - 01/2012
2	Blindness (Hysterical Blindness) 11/2009 - 01/2009
2	vitreous floaters 01/2009 - 01/2005
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2009 - 01/2005
1	Necrosis 12/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2015
1	Dyslipidemias (Dyslipidemia) 04/2015
1	Ischemic Stroke 01/2015
1	Virus Diseases (Viral Diseases) 05/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2014
1	Lung Diseases (Lung Disease) 03/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2014
1	Intellectual Disability (Idiocy) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Cognitive Dysfunction 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014

Drug/Important Bio-Agent (IBA)

30	CarnosineIBA 01/2016 - 01/2005
27	N-acetylcarnosineIBA 12/2016 - 01/2002
18	Lubricant Eye Drops (Artificial Tears)IBA 12/2016 - 01/2004
17	Pharmaceutical PreparationsIBA 01/2015 - 01/2004
13	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2009
13	AntioxidantsIBA 12/2016 - 10/2008
13	carcinineIBA 04/2015 - 01/2010
12	imidazoleIBA 04/2015 - 01/2010
10	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016 - 01/2009
10	ProdrugsIBA 01/2014 - 01/2005
9	Free RadicalsIBA 04/2015 - 01/2004
9	DipeptidesIBA 01/2015 - 01/2009
9	Ophthalmic Solutions (Eye Drops)IBA 07/2010 - 01/2005
6	Histidine (L-Histidine)FDA Link 01/2016 - 01/2009
6	LipidsIBA 04/2011 - 01/2004
5	Glutathione (Reduced Glutathione)IBA 04/2015 - 01/2004
5	Biological ProductsIBA 01/2015 - 07/2010
5	Crystallins (Crystallin)IBA 08/2012 - 01/2004
4	Oxidants (Oxidizing Agents)IBA 01/2016 - 04/2011
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016 - 01/2005
4	Advanced Glycation End ProductsIBA 04/2015 - 01/2009
4	Peptides (Polypeptides)IBA 04/2015 - 01/2012
4	aminoacyl-histidine dipeptidaseIBA 01/2013 - 01/2009
4	Molecular Chaperones (Chaperone, Molecular)IBA 08/2012 - 11/2010
3	MetalsIBA 01/2015 - 01/2009
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 11/2011
3	PeptidomimeticsIBA 12/2013 - 01/2011
3	Retinaldehyde (Retinal)IBA 02/2012 - 01/2005
3	HydrazinesIBA 11/2009 - 01/2009
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2016 - 01/2014
2	EnzymesIBA 04/2015 - 01/2009
2	LigandsIBA 05/2014 - 01/2009
2	Peroxynitrous Acid (Peroxynitrite)IBA 01/2013 - 01/2012
2	Superoxides (Superoxide)IBA 01/2013 - 01/2012
2	CytokinesIBA 01/2013 - 01/2012
2	AnserineIBA 01/2013 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2013 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 01/2012
2	Amino Acids FDA Link 11/2011 - 07/2010
2	LubricantsIBA 11/2011 - 11/2009
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2011 - 01/2009
2	Acetylcysteine (Siran)FDA LinkGeneric 07/2010 - 01/2009
2	AldehydesIBA 11/2009 - 01/2009
2	Lipid PeroxidesIBA 01/2009 - 04/2006
2	SolutionsIBA 01/2004 - 01/2002
1	Hormones (Hormone)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2015
1	polyolIBA 04/2015
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 04/2015
1	EpitopesIBA 05/2014
1	Hemagglutinins (Hemagglutinin)IBA 05/2014
1	Complement System Proteins (Complement)IBA 05/2014
1	ChemokinesIBA 05/2014
1	Antiviral Agents (Antivirals)IBA 05/2014
1	Dosage Forms (Dosage Form)IBA 05/2014
1	Nicotine FDA Link 03/2014

Therapy/Procedure

11	Therapeutics 10/2012 - 01/2009
5	Lenses 08/2012 - 01/2005
2	Ophthalmic Administration 12/2015 - 01/2009
2	Nutritional Support (Artificial Feeding) 03/2015 - 01/2014
1	Home Nursing (Nursing, Home) 01/2016